Covered recipient · General Payments record
AMY M TURNER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$10,799.58
- Reported across 554 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,006.17 | 89 |
| Education | $22.80 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $290.51 | 11 |
| Novo Nordisk AS | $270.80 | 15 |
| Lilly USA, LLC | $233.46 | 11 |
| SANOFI-AVENTIS U.S. LLC | $182.74 | 5 |
| ABBVIE INC. | $125.78 | 6 |
| Xeris Pharmaceuticals, Inc. | $101.66 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $91.21 | 4 |
| Amgen Inc. | $82.81 | 4 |
| Medtronic, Inc. | $82.03 | 4 |
| Nevro Corp. | $62.53 | 2 |
| Averitas Pharma Inc. | $61.88 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $47.75 | 3 |
| Corcept Therapeutics | $45.95 | 2 |
| Ascensia Diabetes Care US Inc. | $43.52 | 2 |
| Kyowa Kirin, Inc. | $28.90 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.38 | 1 |
| Tandem Diabetes Care, Inc. | $24.83 | 1 |
| BETA BIONICS, INC. | $23.90 | 1 |
| IBSA Pharma Inc. | $23.87 | 1 |
| OPKO Pharmaceuticals, LLC | $22.80 | 1 |
| Ascendis Pharma Inc | $22.29 | 1 |
| Antares Pharma, Inc. | $21.08 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.94 | 1 |
| SHIELD THERAPEUTICS INC | $20.11 | 1 |
| Amneal Pharmaceuticals LLC | $19.76 | 1 |
| CeQur Corporation | $18.54 | 1 |
| Astellas Pharma US Inc | $16.14 | 1 |
| DEXCOM, INC. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (90)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.